Pentabromopseudilin (PBrP) exhibits antibacterial, antitumor, and phytotoxic activities; it is a reversible allosteric inhibitor of myosin Va (MyoVa) and a potent inhibitor of transforming growth factor-β (TGF-β) activity; it can be used in research on fibrotic diseases and cancer.